Response of early chick embryos to busulfan
- 1 February 1980
- journal article
- research article
- Published by Wiley in Teratology
- Vol. 21 (1) , 1-8
- https://doi.org/10.1002/tera.1420210102
Abstract
Busulfan, suspended in peanut oil, was injected into the yolk sac of white Leghorn chick embryos in dosages of 0.1 mg, 0.5 mg, or 1.0 mg. Embryos received a single injection of busulfan either prior to incubation, at 24, 48, 72, or 96 hours of incubation. Surviving embryos were sacrificed when they reached five days of incubation. Some embryos exposed to busulfan at 96 hours were allowed to develop to nine days of incubation to determine whether the time of initial exposure or the length of exposure to busulfan was more critical. The embryo required 48 hours to manifest the deleterious effects of busulfan. Abnormalities such as defects in the formation of the limb buds and cephalic hematomas were commonly seen in survivors no matter when exposed to busulfan. Some embryos injected at 96 hours and allowed to develop to nine days displayed edema of the body cavities. The role of busulfan in eliciting these malfomations is discussed.This publication has 20 references indexed in Scilit:
- Myeloschisis in a six weeks embryo of a leukemic woman treated by busulfanTeratology, 1978
- The teratogenic effects of 6-mercaptopurine on chick embryos in ovoTeratology, 1975
- The site and sequence of action of 6-aminonicotinamide in causing bone malformations of embryonic chick limb and its relationship to normal developmentDevelopmental Biology, 1972
- Pregnancy and concurrent chronic myelogenous leukemiaAmerican Journal of Obstetrics and Gynecology, 1972
- Mutagenic alkylating agents as growth inhibitors and carcinogensMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1969
- CYTOTOXIC DRUGS IN PREGNANCYBJOG: An International Journal of Obstetrics and Gynaecology, 1968
- Busulfan in PregnancyJAMA, 1965
- Der Einfluss von Myleran auf die Keimdrüsen von RattenCellular and Molecular Life Sciences, 1953
- MYLERAN IN CHRONIC MYELOID LEUKÆMIA RESULTS OF TREATMENTThe Lancet, 1953
- MYLERAN IN CHRONIC MYELOID LEUKÆMIA CHEMICAL CONSTITUTION AND BIOLOGICAL ACTIONThe Lancet, 1953